BookmarkSubscribeRSS Feed
liao7899
Calcite | Level 5

Dear all,

 

I hope this could the right place to raise a question regarding the technical details for sample size determination using proc power for comparing two survival curves:
http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_power_a00000...

 

My question is to understand the calculation of N(i+1) specified as
                           N_{j}(i+1) = N_{j}(i) * [1-h_{j}(t_{i})*(1/b) - \phi_{j}(t_{i})*(1/b) - (1/b)*(1/(T-\tao-t_{i}))* I_{t_{i}>\tao})]

It looks as if the very last term 1/(T+\tao-t_{i}) is for administrative censoring (i.e., patients who enrolled late in the accrual phase and survival longer than \tao could be censored due to study closure). For example, suppose that subject live forever and will never be censored, (i.e., h(t)=0 and \phi(t)=0 for all t), suppose that N(0)=100, T=4, \tao=0 and b=1, then:
N(1) = 100*(1-1/3).

However, assuming subject entry is uniformed distributed between [0,4] then only subject enters from [3,4] could be censored and should the right answer for N(1) is
75 = 100*(1-1/4)?

 

I really appreciate the insights from you .

 

1 REPLY 1
liao7899
Calcite | Level 5

Problem solved based on Cantor 1997 pp 83-92 and Joanna H Shih 1995 (Sample Size Calculation for Complex Clinical Trials with Survival Endpoints).

 

 

SAS Innovate 2025: Save the Date

 SAS Innovate 2025 is scheduled for May 6-9 in Orlando, FL. Sign up to be first to learn about the agenda and registration!

Save the date!

What is ANOVA?

ANOVA, or Analysis Of Variance, is used to compare the averages or means of two or more populations to better understand how they differ. Watch this tutorial for more.

Find more tutorials on the SAS Users YouTube channel.

Discussion stats
  • 1 reply
  • 1627 views
  • 0 likes
  • 1 in conversation